表紙
市場調査レポート

細胞増殖の世界市場 〜2021年:製品 (試薬・媒体・フローサイトメーター・遠心分離機・バイオリアクター)、細胞種類、用途 (再生医療・幹細胞研究・癌)、エンドユーザー別

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021

発行 MarketsandMarkets 商品コード 318042
出版日 ページ情報 英文 190 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
細胞増殖の世界市場 〜2021年:製品 (試薬・媒体・フローサイトメーター・遠心分離機・バイオリアクター)、細胞種類、用途 (再生医療・幹細胞研究・癌)、エンドユーザー別 Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021
出版日: 2016年06月09日 ページ情報: 英文 190 Pages
概要

世界の細胞増殖市場は、2016年から2021年の間に17.6%のCAGRで拡大し、2016年の83億4,000万米ドルから2021年までに187億6,000万米ドルに達すると予測されています。この成長の主な要因には、研究に対する政府投資の拡大、慢性疾患の高い罹患率、細胞ベース製品開発への企業投資の増加、および医薬品適正製造基準(CMP)認証の細胞療法製造施設数の増加などがあります。また、新興市場の高い潜在的成長力によって多くの市場機会が開かれてきました。しかし、細胞研究の高コストおよび倫理的な懸念が、同市場の成長を抑制すると予測されています。 北米は細胞増殖市場において優勢であり、糖尿病や癌などの慢性疾患の罹患率の増加が成長の主な促進要因となっています。

当レポートでは、世界の細胞増殖市場について調査し、市場動向、産業概要および市場影響因子の分析、用途・エンドユーザー・地域別による現在の市場需要と予測、および主要企業のプロファイルなどをまとめ、お届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • 世界の細胞増殖市場:製品別
  • 世界の細胞増殖市場:細胞種類別
  • 世界の細胞増殖市場:用途別
  • 世界の細胞増殖市場:地域別概要
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 推進因子
      • 慢性疾患の発生率の増加
      • 細胞研究に対する政府投資の増加
      • 企業による細胞治療の研究・開発に対する取り組みの増加
      • 医薬品適正製造基準(CMP)認証の細胞療法製造施設数の増加
    • 阻害因子
      • 細胞生物学における研究の高コスト
      • 細胞生物学の研究に関する倫理的懸念
    • 市場機会
      • 新興国による高成長の機会
      • 3D細胞増殖技術:新しい機会
    • 課題
      • 小規模企業および新規参入企業のサバイバル

第6章 細胞増殖市場:製品別

  • イントロダクション
  • 消耗品
    • 試薬・媒体・血清
    • 使い捨て用品
      • 組織培養フラスコ
      • バイオリアクター付属品
      • その他の使い捨て用品
  • 装置
    • 細胞増殖支援装置
      • フローサイトメーター
      • 遠心分離機
      • 細胞計数器
      • その他の装置
    • バイオリアクター
      • マイクロキャリアバイオリアクター
      • かん流/ホローファイバーバイオリアクター
    • 自動細胞増殖システム

第7章 細胞増殖市場:細胞種類別

  • イントロダクション
  • ヒト細胞
    • 幹細胞
    • 分化細胞
  • 動物細胞

第8章 細胞増殖市場:用途別

  • イントロダクション
  • 再生医療および幹細胞研究
  • 癌および細胞生物学の研究
  • その他

第9章 細胞増殖市場:エンドユーザー別

  • イントロダクション
  • 研究機関
  • バイオテクノロジー&生物製剤企業
  • 細胞バンク

第10章 細胞増殖市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州諸国
  • アジア
    • 日本
    • 中国
    • インド
    • その他のアジア
  • 世界のその他の地域

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況および動向
    • 新製品の市場投入
    • 契約&共同開発
    • 拡張
    • 買収
    • その他の動向

第12章 企業プロファイル

  • Thermo Fisher Scientific, Inc.
    • 事業概要
    • 製品
    • 企業概要
    • 最新動向
    • MnMの視点
  • GE Healthcare (General Electric Companyの全額出資子会社)
  • Lonza Group Ltd.
  • Becton, Dickinson and Company
  • Corning Inc.
  • Merck KGAA
  • Beckman Coulter Inc. (Danaher Corporation子会社)
  • Miltenyi Biotec
  • Stemcell Technologies
  • Terumo BCT, Inc.(テルモの子会社)

第13章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 2850

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, end user, and region. The consumables segment is expected to register the highest growth rate in the cell expansion market, by product, during the forecast period. The high growth in this segment is attributed to the increasing investments in cell-based research.

Based on end user, the cell expansion market is segmented into research institutes, biopharmaceutical and biotechnology companies, cell banks, and others. The research institutes segment is expected to account for the largest share of the market in 2016. The increasing prevalence of diseases and the need to develop new therapies will drive the growth of this market.

Geographically, the cell expansion market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for research in the North American countries.

The major factors contributing to the growth of the cell expansion market include increasing government funding for research, high prevalence of chronic diseases, and growing number of GMP-certified production facilities. Furthermore, increasing R&D spending and new product development activities by companies is another major factor driving the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise product portfolios, developments, and strategies adopted by market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, changes in strategic approach, and levels of output in order to remain successful in the market.

The major players in this market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Corning, Inc. (U.S.), GE Healthcare (U.K.), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the cell expansion market. The report analyses the cell expansion market by product, cell type, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the cell expansion market
  • Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the cell expansion market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various cell expansion market products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell expansion market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKET SEGMENTATION
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATION
  • 1.5. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. KEY INDUSTRY INSIGHTS
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. CELL EXPANSION MARKET OVERVIEW
  • 4.2. CELL EXPANSION MARKET, BY PRODUCT
  • 4.3. GEOGRAPHIC ANALYSIS: CELL EXPANSION MARKET, BY CELL TYPE
  • 4.4. CELL EXPANSION MARKET, BY APPLICATION
  • 4.5. GEOGRAPHICAL SNAPSHOT OF THE CELL EXPANSION MARKET
  • 4.6. LIFECYCLE ANALYSIS, BY REGION, 2016

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing incidence of chronic diseases
      • 5.3.1.2. Rising government investments for cell-based research
      • 5.3.1.3. Increasing initiatives by companies for research and development of cell-based therapies
      • 5.3.1.4. Increasing number of GMP-certified cell therapy production facilities
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High cost of cell-based research
      • 5.3.2.2. Ethical concerns regarding research on cell biology
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging countries to present high-growth opportunities
      • 5.3.3.2. 3D cell expansion technology: A new opportunity
    • 5.3.4. CHALLENGE
      • 5.3.4.1. Survival of small players and new entrants

6. CELL EXPANSION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. REAGENTS, MEDIA, AND SERUM
    • 6.2.2. DISPOSABLES
      • 6.2.2.1. Tissue culture flasks
      • 6.2.2.2. Bioreactor accessories
      • 6.2.2.3. Other disposables
  • 6.3. INSTRUMENTS
    • 6.3.1. CELL EXPANSION SUPPORTING EQUIPMENT
      • 6.3.1.1. Flow cytometers
      • 6.3.1.2. Centrifuges
      • 6.3.1.3. Cell counters
      • 6.3.1.4. Other supporting equipment
    • 6.3.2. BIOREACTORS
      • 6.3.2.1. Microcarrier bioreactors
        • 6.3.2.1.1. Microcarrier-based anchorage-dependent bioreactors
        • 6.3.2.1.2. Suspension-based anchorage independent bioreactors
      • 6.3.2.2. Perfusion/hollow fiber bioreactors
    • 6.3.3. AUTOMATED CELL EXPANSION SYSTEMS

7. CELL EXPANSION MARKET, BY CELL TYPE

  • 7.1. INTRODUCTION
  • 7.2. HUMAN CELLS
    • 7.2.1. STEM CELLS
      • 7.2.1.1. Adult stem cells
      • 7.2.1.2. Induced pluripotent stem cells
      • 7.2.1.3. Embryonic stem cells
    • 7.2.2. DIFFERENTIATED CELLS
  • 7.3. ANIMAL CELLS

8. CELL EXPANSION MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. REGENERATIVE MEDICINE AND STEM CELL RESEARCH
  • 8.3. CANCER AND CELL-BASED RESEARCH
  • 8.4. OTHERS

9. CELL EXPANSION MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. RESEARCH INSTITUTES
  • 9.3. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 9.4. CELL BANKS
  • 9.5. OTHERS

10. CELL EXPANSION MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE
  • 10.4. ASIA
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. NEW PRODUCT LAUNCHES
    • 11.3.2. AGREEMENTS AND COLLABORATIONS
    • 11.3.3. EXPANSIONS
    • 11.3.4. ACQUISITIONS
    • 11.3.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. THERMO FISHER SCIENTIFIC, INC.
  • 12.3. GE HEALTHCARE (A WHOLLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 12.4. LONZA GROUP LTD.
  • 12.5. BECTON, DICKINSON AND COMPANY
  • 12.6. CORNING, INC.
  • 12.7. MERCK KGAA
  • 12.8. BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION)
  • 12.9. MILTENYI BIOTEC
  • 12.10. STEMCELL TECHNOLOGIES
  • 12.11. TERUMO BCT, INC. (A SUBSIDIARY OF TERUMO CORPORATION)

*Details on company financial might not be captured in case of unlisted companies

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: RISING INCIDENCES OF CANCER, BY TYPE (IN THOUSANDS)
  • TABLE 2: NATIONAL INSTITUTES OF HEALTH (NIH) FUNDING IN THE U.S., 2013-2016 (USD MILLION)
  • TABLE 3: R&D EXPENDITURE OF BIOTECHNOLOGY FIRMS, BY COUNTRY
  • TABLE 4: CELLULAR AND GENE THERAPY MARKETED PRODUCTS APPROVED BY FDA
  • TABLE 5: RISING REGULATORY APPROVALS FOR GOOD MANUFACTURING PRACTICES TO BOOST THE MARKET
  • TABLE 6: INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING GOVERNMENT INVESTMENTS ARE DRIVING THE CELL EXPANSION MARKET
  • TABLE 7: HIGH COST OF CELL-BASED RESEARCH IS EXPECTED TO RESTRAIN MARKET GROWTH
  • TABLE 8: ASIAN ECONOMIES TO CREATE NEW GROWTH OPPORTUNITIES IN THE MARKET
  • TABLE 9: SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS IS A MAJOR CHALLENGE IN THE CELL EXPANSION MARKET
  • TABLE 10: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 11: CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CONSUMABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: EUROPE: CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: ASIA: CONSUMABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: CONSUMABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 16: REAGENTS, MEDIA, AND SERUM MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: DISPOSABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: DISPOSABLES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: TISSUE CULTURE FLASKS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: BIOREACTOR ACCESSORIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: OTHER DISPOSABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: EUROPE: INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: ASIA: INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 27: CELL EXPANSION SUPPORTING EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: CELL EXPANSION SUPPORTING EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: FLOW CYTOMETER MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: CENTRIFUGE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: CELL COUNTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: OTHER SUPPORTING EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: BIOREACTOR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: BIOREACTOR MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 35: MICROCARRIER BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: MICROCARRIER BIOREACTOR MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 37: MICROCARRIER-BASED ANCHORAGE-DEPENDENT BIOREACTOR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: SUSPENSION-BASED ANCHORAGE INDEPENDENT BIOREACTOR MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: PERFUSION/HOLLOW FIBER BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: AUTOMATED CELL EXPANSION SYSTEM MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 42: HUMAN CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: HUMAN CELLS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: STEM CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: STEM CELLS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: GOVERNMENT INVESTMENTS FOR ENHANCING STEM CELL RESEARCH, 2013-2015
  • TABLE 47: ADULT STEM CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: RISING INCIDENCE OF DISEASES TO TRIGGER MARKET GROWTH
  • TABLE 49: INDUCED PLURIPOTENT STEM CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: EMBRYONIC STEM CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: DIFFERENTIATED CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: ANIMAL CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 54: REGENERATIVE MEDICINES AND STEM CELL RESEARCH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: CANCER AND CELL-BASED RESEARCH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: OTHERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 58: RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: CELL BANKS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: OTHERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: WORLDWIDE NUMBER OF DEATHS, BY DISEASE, 2008-2030 (IN THOUSANDS)
  • TABLE 63: CELL EXPANSION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 64: NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 66: NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: NORTH AMERICA: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: NORTH AMERICA: CELL EXPANSION MARKET SIZE FOR STEM CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 76: NORTH AMERICA: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 77: U.S.: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: U.S.: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: U.S.: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 80: U.S.: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 81: CANADA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 82: CANADA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: CANADA: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 84: CANADA: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 85: EUROPE: CELL EXPANSION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 87: EUROPE: CELL EXPANSION MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: EUROPE: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: EUROPE: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: EUROPE: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: EUROPE: CELL EXPANSION MARKET SIZE FOR BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: EUROPE: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: EUROPE: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: EUROPE: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: EUROPE: CELL EXPANSION MARKET SIZE FOR STEM CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: EUROPE: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 97: EUROPE: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 98: GERMANY: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 99: GERMANY: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 100: GERMANY: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 101: GERMANY: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 102: U.K.: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 103: U.K.: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: U.K.: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 105: U.K.: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 106: FRANCE: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 107: FRANCE: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: FRANCE: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 109: FRANCE: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 110: ITALY: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 111: ITALY: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: ITALY: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 113: ITALY: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 114: SPAIN: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 115: SPAIN: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 116: SPAIN: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 117: SPAIN: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 118: ROE: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 119: ROE: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 120: ROE: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 121: ROE: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 122: ASIA: CELL EXPANSION MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 123: ASIA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 124: ASIA: CELL EXPANSION MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: ASIA: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: ASIA: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 127: ASIA: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 128: ASIA: CELL EXPANSION MARKET SIZE FOR BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: ASIA: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 130: ASIA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 131: ASIA: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: ASIA: CELL EXPANSION MARKET SIZE FOR STEM CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: ASIA: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 134: ASIA: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 135: INVESTMENTS IN MEDICAL RESEARCH PROJECTS, 2014
  • TABLE 136: JAPAN: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 137: JAPAN: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 138: JAPAN: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 139: JAPAN: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 140: CHINA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 141: CHINA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: CHINA: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 143: CHINA: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 144: INDIA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 145: INDIA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 146: INDIA: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 147: INDIA: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 148: ROA: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 149: ROA: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 150: ROA: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 151: ROA: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 152: ROW: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 153: ROW: CELL EXPANSION MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 154: ROW: CELL EXPANSION CONSUMABLES MARKET SIZE FOR DISPOSABLES, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 155: ROW: CELL EXPANSION MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 156: ROW: CELL EXPANSION MARKET SIZE FOR SUPPORTING EQUIPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 157: ROW: CELL EXPANSION MARKET SIZE FOR BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 158: ROW: CELL EXPANSION BIOREACTORS MARKET SIZE FOR MICROCARRIER BIOREACTORS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 159: ROW: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 160: ROW: CELL EXPANSION MARKET SIZE FOR HUMAN CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 161: ROW: CELL EXPANSION MARKET SIZE FOR STEM CELLS, BY CELL TYPE, 2014-2021 (USD MILLION)
  • TABLE 162: ROW: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 163: ROW: CELL EXPANSION MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 164: NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 165: AGREEMENTS AND COLLABORATIONS, 2013-2016
  • TABLE 166: EXPANSIONS, 2013-2016
  • TABLE 167: ACQUISITIONS, 2013-2016
  • TABLE 168: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: CELL EXPANSION MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: TOP-DOWN APPROACH
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 1: CELL EXPANSION MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
  • FIGURE 2: CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 3: CELL EXPANSION MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 4: ELL EXPANSION MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 5: ELL EXPANSION MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 6: ELL EXPANSION MARKET TO SHOWCASE HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 7: ONSUMABLES SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 8: UMAN CELLS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 9: EGENERATIVE MEDICINE AND STEM CELL RESEARCH APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 10: U.S. TO DOMINATE THE CELL EXPANSION MARKET IN 2016
  • FIGURE 11: ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE CELL EXPANSION MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: CELL EXPANSION MARKET SEGMENTATION
  • FIGURE 13: CELL EXPANSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14: GLOBAL PREVALENCE OF DIABETES, BY REGION (IN MILLION)
  • FIGURE 15: CONSUMABLES SEGMENT IS EXPECTED TO DOMINATE THE CELL EXPANSION PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: TISSUE CULTURE FLASK TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: CELL EXPANSION SUPPORTING EQUIPMENT IS EXPECTED TO GROW AT HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 18: ASIA TO GROW AT THE HIGHEST CAGR IN THE BIOREACTOR MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: HUMAN CELLS SEGMENT EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: ADULT STEM CELLS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: REGENERATIVE MEDICINE AND STEM CELL RESEARCH EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 22: ASIA IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 23: RESEARCH INSTITUTES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2016
  • FIGURE 24: ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 25: GEOGRAPHIC SNAPSHOT: EMERGING MARKETS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 26: NORTH AMERICA: CELL EXPANSION MARKET SNAPSHOT
  • FIGURE 27: EUROPE: CELL EXPANSION MARKET SNAPSHOT
  • FIGURE 28: EUROPE: ESTIMATED NUMBER OF NEW CANCER CASES, 2012-2020 (IN THOUSANDS)
  • FIGURE 29: ASIA: CELL EXPANSION MARKET SNAPSHOT
  • FIGURE 30: ASIA: AN ATTRACTIVE MARKET FOR CELL EXPANSION
  • FIGURE 31: NEW PRODUCT LAUNCH IS THE KEY GROWTH STRATEGY FOR MARKET PLAYERS FROM 2013 TO 2016
  • FIGURE 32: GLOBAL CELL EXPANSION MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 33: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCH IS THE PREFERRED STRATEGY FOR MARKET PLAYERS
  • FIGURE 34: PRODUCT BENCHMARKING FOR TOP 6 MARKET PLAYERS
  • FIGURE 35: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 36: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • FIGURE 37: LONZA GROUP LTD.: COMPANY SNAPSHOT
  • FIGURE 38: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 39: CORNING, INC.: COMPANY SNAPSHOT
  • FIGURE 40: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 41: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 42: TERUMO CORPORATION: COMPANY SNAPSHOT
Back to Top